CELESIA, BENEDETTO MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 3.957
AS - Asia 1.992
EU - Europa 1.362
SA - Sud America 420
AF - Africa 290
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.028
Nazione #
US - Stati Uniti d'America 3.846
SG - Singapore 948
CN - Cina 624
IT - Italia 474
BR - Brasile 357
IE - Irlanda 260
CI - Costa d'Avorio 191
DE - Germania 143
VN - Vietnam 143
UA - Ucraina 137
IN - India 93
FI - Finlandia 88
CA - Canada 73
KR - Corea 60
RU - Federazione Russa 49
GB - Regno Unito 48
SN - Senegal 41
SE - Svezia 33
NL - Olanda 31
MX - Messico 28
PL - Polonia 25
AR - Argentina 23
HK - Hong Kong 22
NG - Nigeria 20
BD - Bangladesh 16
ZA - Sudafrica 15
BE - Belgio 13
ID - Indonesia 12
CO - Colombia 11
EC - Ecuador 11
IQ - Iraq 11
JP - Giappone 11
AT - Austria 10
FR - Francia 10
ES - Italia 9
BJ - Benin 8
CH - Svizzera 8
TR - Turchia 8
IR - Iran 7
PK - Pakistan 6
PY - Paraguay 6
AU - Australia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
KE - Kenya 5
BG - Bulgaria 4
CL - Cile 4
LB - Libano 4
MA - Marocco 4
SA - Arabia Saudita 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BH - Bahrain 2
DK - Danimarca 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
IL - Israele 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MW - Malawi 1
NR - Nauru 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 8.028
Città #
Dallas 897
Santa Clara 625
Singapore 530
Chandler 378
Dublin 259
Abidjan 191
Beijing 161
Chicago 158
Ashburn 157
Jacksonville 150
Los Angeles 148
Hefei 138
Boardman 115
Catania 102
Munich 89
New York 81
Cambridge 64
Lawrence 64
Seoul 60
Civitanova Marche 57
Andover 55
Ho Chi Minh City 52
Helsinki 50
Kochi 48
Dakar 41
Toronto 41
São Paulo 36
Des Moines 35
Nanjing 34
Buffalo 30
Hanoi 28
Nanchang 25
Lappeenranta 24
Rome 24
Houston 22
Warsaw 22
Wilmington 22
Hong Kong 21
Abuja 20
The Dalles 20
Brooklyn 19
Columbus 18
Atlanta 17
Denver 17
Milan 16
San Mateo 15
Amsterdam 14
Boston 14
Modica 14
Montreal 14
Palermo 14
Brussels 13
Mexico City 13
Parma 13
Chennai 12
Grafing 12
Philadelphia 12
Phoenix 12
Rende 12
Rio de Janeiro 12
Shenyang 12
Bremen 11
Changsha 11
Dong Ket 11
Jiaxing 11
Milazzo 11
Tremestieri Etneo 11
Hebei 10
Johannesburg 10
Mumbai 10
Orem 10
Ottawa 10
Poplar 10
Tokyo 10
Council Bluffs 9
Saint Petersburg 9
Cotonou 8
London 8
San Francisco 8
Stockholm 8
Tianjin 8
Turku 8
Redwood City 7
Seattle 7
Augusta 6
Bari 6
Brasília 6
Charlotte 6
Fortaleza 6
New Delhi 6
Porto Alegre 6
Reggio Emilia 6
Campinas 5
Curitiba 5
Guarulhos 5
Jinan 5
Nairobi 5
Norwalk 5
Salvador 5
San Giovanni la Punta 5
Totale 5.673
Nome #
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 287
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 122
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 122
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 111
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 111
[In Process Citation] 110
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 109
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 106
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 101
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 97
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 94
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 93
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 92
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 91
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 91
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 91
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 90
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 90
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 90
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 89
Kidney disease in HIV-infected patients 88
Hepatic echinococcosis: clinical and therapeutic aspects 88
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 87
Factors predicting tuberculosis reactivation in HIV-infected patients [PARAMETRI PREDITTIVI DI RIATTIVAZIONE TUBERCOLARE IN SOGGETTI CON INFEZIONE DA HIV] 87
Efficacy and safety of Atazanavir/Ritonavir therapy in a cohort of treatment-experienced patients 86
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 83
Trimethoprim-sulfamthoxazole associated severe hypoglicemia: a sulfnylurea like effect 82
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 82
Anxiety disorders and adherence to HAART 80
Analysis of impediments to the maintenance in care of people with HIV in Italy 80
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy 80
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 80
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 78
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 78
Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature 78
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 77
Ruolo del rapporto eterosessuale nella trasmissione dell’infezione HIV in un gruppo di tossicodipendenti della Sicilia Orientale. Necessità di modificare le strategie di prevenzione? 77
Editorial-Coronavirus disease 2019 and people living with HIV: Clinical considerations 77
Sifilide ed HIV.Presentazione di tre casi clinici 77
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 76
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 76
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 75
Successful extracorporeal membrane oxygenation treatment in an acquired immune deficiency syndrome (AIDS) patient with acute respiratory distress syndrome (ARDS) complicating pneumocystis jirovecii pneumonia: A challenging case 74
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review 74
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature 72
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 72
Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience 72
Possible role of low dose dexamethasone administration in listeria monocytogenes meningoencephalitis: A case series 71
Serum tumor necrosis factor in acute and fulminant hepatitis B 70
Microbial translocation in chronic liver diseases 70
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 70
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 69
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment 69
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 69
Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment 68
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 68
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily 67
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals 65
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 65
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review 64
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 64
Localizzazione osteoarticolare multipla in corso di sepsi da Staphylococcus aureus meticillino-resistente: Considerazioni clinico- terapeutiche [Multiple osteo-articular involvement due to methicillin-resistant Staphylococcus aureus septicaemia: clinical and therapeutic evaluation] 63
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 61
HCV and HIV infection among intravenous drug abusers in eastern Sicily 60
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 60
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 60
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 59
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: A cross-sectional study 58
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 57
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 55
Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study 55
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 54
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 54
Serum cytokines as predictors of clinical outcome in AIDS-related intestinal cryptosporidiosis 54
Prevalenza e distribuzione dell’HHV-8 in differenti popolazioni con e senza infezione da HIV 54
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 54
Sexual dysfunction in HIV plus subjects in eastern Sicily 54
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 52
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment 51
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 51
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 51
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 51
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey 50
Prevalence of HLA-B*5701 and access to genetic test in Sicily. A multicenter study 50
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 47
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 46
New HIV diagnosis and linkage to care in two outpatient units in South Europe 46
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 45
Ageing with HIV: a multidisciplinary review 45
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 44
Factors associated with weight gain in people treated with dolutegravir 43
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report 41
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 41
Evaluation of HIV transmission cluster among natives and foreigners living Italy 40
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 40
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 37
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 37
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 36
Weight gain: A possible side effect of all antiretrovirals 36
PrEP in Italy: The time may be ripe but who’s paying the bill? A nationwide survey on physicians’ attitudes towards using antiretrovirals to prevent HIV infection 36
Totale 7.200
Categoria #
all - tutte 31.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 0 69 14 29 0 35 24 52 18
2021/2022469 39 61 12 5 65 8 72 27 46 11 20 103
2022/20231.035 71 67 14 101 106 171 5 177 245 5 40 33
2023/2024496 28 63 21 32 22 135 5 35 4 22 79 50
2024/20252.656 25 287 110 104 567 334 92 86 236 276 293 246
2025/20262.914 382 380 1.081 530 541 0 0 0 0 0 0 0
Totale 8.250